The study sought to establish whether surgical or non-surgical therapy was superior for treating malignant bowel obstruction (MBO) in advanced cancer patients. The experiment involved 221 individuals with MBO who were considered surgical candidates. One-quarter were randomly assigned to either surgery or non-surgical therapy, while the others chose their treatment in consultation with their doctor. The number of “good days—defined as days alive and out of the hospital—did not differ substantially between the two treatment options, according to the researchers. The ability to consume after 5 weeks was likewise comparable. Patients who had surgery, on the other hand, experienced less severe symptoms of vomiting, constipation, nausea, and pain after 4 weeks when compared to those who were not treated surgically. Patients who were hospitalized and had surgery, in particular, reported fewer MBO-related symptoms when they were discharged.

To know more: About the original article click here.